Identifying methamphetamine exposure in children

Therapeutic Drug Monitoring

Volumn 35, Issue 6, 2013, Pages 823-830

  Castaneto, Marisol S ^a   Barnes, Allan J ^a   Scheidweiler, Karl B ^a   Schaffer, Michael ^b   Rogers, Kristen K ^c   Stewart, Deborah ^d   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Psychemedics Corporation   (United States)

^c California Department of Public Health   (United States)

^d CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Drug exposed children; Hair; Methamphetamine; Oral fluid; Urine

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; METHAMPHETAMINE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DRUG DETERMINATION; DRUG EXPOSURE; DRUG HAIR LEVEL; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG SCREENING; DRUG URINE LEVEL; HAIR COLOR; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MASS FRAGMENTOGRAPHY; ORAL FLUID; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE DIFFERENCE; SCHOOL CHILD; TANDEM MASS SPECTROMETRY;

ADOLESCENT; AMPHETAMINE-RELATED DISORDERS; AMPHETAMINES; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; ENVIRONMENTAL EXPOSURE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HAIR; HUMANS; INFANT; INFANT, NEWBORN; METHAMPHETAMINE; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION;

EID: 84889265018     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31829685b2     Document Type: Article

References (41)

1. Federal Interagency Task Force on Drug Endangered Children. Promising Practices Toolkit: Working with Drug Endangered Children and Their Families. Rockville, MD: National Criminal Justice Reference Service (NCJRS), 2011. Available at: https://www.ncjrs.gov/app/publications/Abstract.aspx?id=256481. Accessed January 31, 2013.
2. Carvalho M, Carmo H, Costa V, et al. Toxicity of amphetamines: an update. Arch Toxicol. 2012;86:1167-1231.
3. Vearrier D, Greenberg MI, Miller SN, et al. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Dis Mon. 2012;58:38-89.
4. UNODC. World Drug Report. United Nations publications; 2012;1-112.
5. Perez-Reyes M, White WR, McDonald SA, et al. Clinical effects of daily methamphetamine administration. Clin Neuropharmacol. 1991; 14:352-358.
6. Hohman M, Oliver R, Wright W. Methamphetamine abuse and manufacture: the child welfare response. Soc Work. 2004;49:373-381. (Pubitemid 39056808)
7. United States Congress. In: Title VII of the USA Patriot Improvement and Reauthorization Act of 2005. The Combat Methamphetamine Epidemic Act of 2005. Washington, D.C: US Department of Justice; 2006. PL No. 109-177.
8. National Drug Intelligence Center Threat Assessment. Johnstown, PA: National Drug Intelligence Center; 2011. Available at: http://www.justice. gov/archive/ndic/pubs44/44849/44849p.pdf. Accessed December 1, 2012.
9. United States Department of Justice. News: 28 People Arrested for Methamphetamine Operation. Washington, DC: US Department of Justice; 2012. Available at: http://www.justice.gov/usao/mie/news/2012/2012-3-14-methoperation. html. Accessed December 1, 2012.
10. Asanbe C, Hall C, Bolden C. The methamphetamine home: psychological impact on preschoolers in rural Tennessee. J Rural Health. 2008;24: 229-234.
11. Farst K, Bolden B. Substance-exposed infants and children: forensic approach. Clin Pediat Emerg Med. 2012;13:221-228.
12. Grant P. Evaluation of children removed from a clandestine methamphetamine laboratory. Clin Pediat Emerg Med. 2006;7:170-178. (Pubitemid 44688640)
13. Messina N, Marinelli-Casey P, West K, et al. Children exposed to methamphetamine use and manufacture. Child Abuse Negl. 2007. Available at: http://dx.doi.org/10.1016/j.chiabu.2006.06.009. Accessed October 15, 2012.
14. Anderson K, Burbach S, Collier M, et al. Washington's endangered children's assessment and response: recommended best practices addressing the needs of drug endangered children. 2004. Available at: http://www.dshs.wa.gov/ pdf/ca/wecare.pdf. Accessed October 15, 2012.
15. Farst K, Reading Meyer MA, Bird TM, et al. Hair drug testing of children suspected of exposure to the manufacture of methamphetamine. J Forensic Leg Med. 2011;18:110-114.
16. Matteucci MJ, Auten JD, Crowley B, et al. Methamphetamine exposures in young children. Pediatr Emerg Care. 2007;23:638-640. (Pubitemid 47429059)
17. Mecham N, Mellini J. Unintentional victims: development of a protocol for the care of children exposed to chemicals at methamphetamine laboratories. Pediatr Emerg Care. 2002;18:327-332.
18. Haight W, Black J, Sheridan K. A mental health intervention for rural foster children from methamphetamine-involved families: experimental assessment with qualitative elaboration. Child Youth Serv Rev. 2010;32: 1146-1457.
19. Cook CE, Jeffcoat AR, Hill JM, et al. Pharmacokinetics of methamphetamine self-administrated to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos. 1993;21:717-723. (Pubitemid 23221770)
20. Huestis MA, Cone E. Methamphetamine disposition in oral fluid, plasma, and urine. Ann N Y Acad Sci. 2007;1098:104-121. (Pubitemid 47092559)
21. Oyler JM, Cone E, Joseph RE, et al. Duration of detectable methamphetamine and amphetamine excretion in urine after control oral administration of methamphetamine in humans. Clin Chem. 2002;48:1703-1714.
22. Barnes AJ, Scheidweiler KB, Kolbrich-Spargo EA, et al. MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA. Ther Drug Monit. 2011;33 602-608.
23. Han E, Paulus MP, Wittman M, et al. Hair analysis and self-report of methamphetamine use by methamphetamine dependent individuals. J Chromatogr Analyt B Technol Biomed Life Sci. 2011;879:541-547.
24. Gouveia CA, Oliveira A, Pinho S, et al. Simultaneous quantification of morphine and cocaine in hair samples from drug addicts by GC-EI/MS. Biomed Chromatogr. 2012;26:1041-1047.
25. Pirnay SO, Abraham TT, Huestis MA. Sensitive gas chromatographymass spectrometry method for simultaneous measurements of MDEA, MDA, and metabolites HMA, MDA, and HMMA in urine. Clin Chem. 2006;52:1728-1735.
26. Scheidweiler KB, Huestis MA. A validated gas chromatographic-electron impact ionization mass spectrometric method for methylenedioxymethamphetamine (MDMA), methamphetamine and metabolites in oral fluid. J Chromatogr Analyt B Technol Biomed Life Sci. 2006;835:90-9910.
27. Cairns T, Hill V, Schaffer M, et al. Amphetamines in washed hair of demonstrated users and workplace subjects. Forensic Sci Int. 2004;145:137-142. (Pubitemid 39296631)
28. Schaffer MI, Wang WL, Irving J. An evaluation of two wash procedures for the differentiation of external contamination versus ingestion in the analysis of human hair samples for cocaine. J Anal Toxicol. 2002;26: 485-488. (Pubitemid 36206784)
29. Grant P, Bell K, Stewart D, et al. Evidence of methamphetamine exposure in children removed from clandestine methamphetamine laboratories. Pediatr Emerg Care. 2010;26:10-14.
30. Bassindale T. Quantitative analysis of methamphetamine in hair of children removed from clandestine laboratories-evidence of passive exposure? Forensic Sci Int. 2012;219:179-182.
31. Polettini A, Cone EJ, Gorelick DA, et al. Incorporation of methamphetamine and amphetamine in human hair following controlled oral methamphetamine administration. Anal Chim Acta. 2012;726:35-46.
32. Cone EJ, Welsch MJ, Babecki BG. Hair Testing for Drugs of Abuse: International Research on Standards and Technology. Bethesda, MD: National Institute of Health; 1995.
33. Lebeau MA, Montgomery MA, Brewer JD. The role of variation in growth rate and sample collection on interpreting results of segmental hair analyses of hair. Forensic Sci Int. 2011;210:110-116.
34. Barth J. Normal hair growth in children. Pediatr Dermatol. 1987;4: 173-184.
35. Martyny JW, Arbuckle SL, McCammon CS, et al. Methamphetamine contamination on environmental surfaces caused by simulated smoking of methamphetamine. J Chem Health Saf. 2008;15:25-31.
36. Ruha AM, Yarema MC. Pharmacologic treatment of acute pediatric methamphetamine toxicity. Pediatr Emerg Care. 2006;22:782-785. (Pubitemid 46045708)
37. Kolecki P. Inadvertent methamphetamine poisoning in pediatric patients. Pediatr Emerg Care. 1998;14:385-387. (Pubitemid 29019055)
38. Salocks CB. Assessment of children's exposure to surface methamphetamine residues in former clandestine methamphetamine labs, and identification of a risk-based clean up standard for surface methamphetamine contamination. Sacramento, CA: Office of Environmental Health Hazard Assessment; 2009. Available at: http://oehha.ca.gov/public-info/public/kids/pdf/ ExposureAnalysis022709.pdf. Accessed October 1, 2012.
39. Ostler T, Bahar OS, Jessee A. Mentalization in children exposed to parental methamphetamine abuse: relations to children's mental health and behavioral outcomes. Attach Hum Dev. 2010;12:193-207.
40. Ostler T, Haight W, Black J, et al. Case series: mental health needs and perspectives of rural children reared by parents who abuse methamphetamines. J Am Acad Child Adolesc Psychiatry. 2007;46:500-507. (Pubitemid 46622759)
41. Joya X, Papaseit E, Civit E, et al. Unsuspected exposure to cocaine in preschool children from a Mediterranean city detected by hair analysis. Ther Drug Monit. 2009;31:391-395.